BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15717937)

  • 1. A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer.
    Shenfine J; McNamee P; Steen N; Bond J; Griffin SM
    Health Technol Assess; 2005 Feb; 9(5):iii, 1-121. PubMed ID: 15717937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial.
    Adamson D; Byrne A; Porter C; Blazeby J; Griffiths G; Nelson A; Sewell B; Jones M; Svobodova M; Fitzsimmons D; Nixon L; Fitzgibbon J; Thomas S; Millin A; Crosby T; Staffurth J; Hurt C
    Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):292-303. PubMed ID: 33610215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative radiotherapy combined with stent insertion to reduce recurrent dysphagia in oesophageal cancer patients: the ROCS RCT.
    Adamson D; Blazeby J; Porter C; Hurt C; Griffiths G; Nelson A; Sewell B; Jones M; Svobodova M; Fitzsimmons D; Nixon L; Fitzgibbon J; Thomas S; Millin A; Crosby T; Staffurth J; Byrne A
    Health Technol Assess; 2021 May; 25(31):1-144. PubMed ID: 34042566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trial.
    Adamson D; Blazeby J; Nelson A; Hurt C; Nixon L; Fitzgibbon J; Crosby T; Staffurth J; Evans M; Kelly NH; Cohen D; Griffiths G; Byrne A
    Trials; 2014 Oct; 15():402. PubMed ID: 25336193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for dysphagia in oesophageal cancer.
    Sreedharan A; Harris K; Crellin A; Forman D; Everett SM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD005048. PubMed ID: 19821338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WITHDRAWN: Interventions for dysphagia in oesophageal cancer.
    Sreedharan A; Harris K; Crellin A; Forman D; Everett SM
    Cochrane Database Syst Rev; 2011 Feb; (2):CD005048. PubMed ID: 21328271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost effectiveness of metal oesophageal stenting in malignant disease compared with conventional therapy.
    Nicholson DA; Haycox A; Kay CL; Rate A; Attwood S; Bancewicz J
    Clin Radiol; 1999 Apr; 54(4):212-5. PubMed ID: 10210338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions for dysphagia in oesophageal cancer.
    Dai Y; Li C; Xie Y; Liu X; Zhang J; Zhou J; Pan X; Yang S
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005048. PubMed ID: 25354795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stents as sole therapy for oesophageal cancer: a prospective analysis of outcomes after placement.
    White RE; Parker RK; Fitzwater JW; Kasepoi Z; Topazian M
    Lancet Oncol; 2009 Mar; 10(3):240-6. PubMed ID: 19230771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomised phase III trial.
    Amdal CD; Jacobsen AB; Sandstad B; Warloe T; Bjordal K
    Radiother Oncol; 2013 Jun; 107(3):428-33. PubMed ID: 23647761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliative stenting for relief of dysphagia in patients with inoperable esophageal cancer: impact on quality of life.
    Madhusudhan C; Saluja SS; Pal S; Ahuja V; Saran P; Dash NR; Sahni P; Chattopadhyay TK
    Dis Esophagus; 2009; 22(4):331-6. PubMed ID: 19473211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-expanding metal stent insertion for inoperable esophageal carcinoma in Belfast: an audit of outcomes and literature review.
    Gray RT; O'Donnell ME; Scott RD; McGuigan JA; Mainie I
    Dis Esophagus; 2011 Nov; 24(8):569-74. PubMed ID: 21418125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-expanding metal oesophageal endoprostheses: which is best?
    Watson A
    Eur J Gastroenterol Hepatol; 1998 May; 10(5):363-5. PubMed ID: 9619379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic analysis of esophageal stenting for management of malignant dysphagia.
    Rao C; Haycock A; Zacharakis E; Krasopoulos G; Yakoub D; Protopapas A; Darzi A; Hanna GB; Athanasiou T
    Dis Esophagus; 2009; 22(4):337-47. PubMed ID: 19207559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cost-benefit comparison of self-expanding metal stents and Atkinson tubes for the palliation of obstructing esophageal tumors.
    Birch JF; White SA; Berry DP; Veitch PS
    Dis Esophagus; 1998 Jul; 11(3):172-6. PubMed ID: 9844799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01).
    Penniment MG; De Ieso PB; Harvey JA; Stephens S; Au HJ; O'Callaghan CJ; Kneebone A; Ngan SY; Ward IG; Roy R; Smith JG; Nijjar T; Biagi JJ; Mulroy LA; Wong R;
    Lancet Gastroenterol Hepatol; 2018 Feb; 3(2):114-124. PubMed ID: 29248399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptable results after self-expanding metallic stent treatment for dysphagia in non-resectable oesophageal cancer.
    Bjerring OS; Pless T; Fristrup C; Mortensen MB
    Dan Med J; 2012 Jun; 59(6):A4459. PubMed ID: 22677249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma.
    Dallal HJ; Smith GD; Grieve DC; Ghosh S; Penman ID; Palmer KR
    Gastrointest Endosc; 2001 Nov; 54(5):549-57. PubMed ID: 11677469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial.
    Homs MY; Steyerberg EW; Eijkenboom WM; Tilanus HW; Stalpers LJ; Bartelsman JF; van Lanschot JJ; Wijrdeman HK; Mulder CJ; Reinders JG; Boot H; Aleman BM; Kuipers EJ; Siersema PD
    Lancet; 2004 Oct 23-29; 364(9444):1497-504. PubMed ID: 15500894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undernutrition is predictive of early mortality after palliative self-expanding metal stent insertion in patients with inoperable or recurrent esophageal cancer.
    Lecleire S; Di Fiore F; Antonietti M; Ben Soussan E; Hellot MF; Grigioni S; Déchelotte P; Lerebours E; Michel P; Ducrotté P
    Gastrointest Endosc; 2006 Oct; 64(4):479-84. PubMed ID: 16996335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.